Gene · 4831
NME2: NME/NM23 nucleoside diphosphate kinase 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NME2: NME/NM23 nucleoside diphosphate kinase 2. Genes, record 4831. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4831
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P22392 | Nucleoside diphosphate kinase B | 152 | 8 | Ensembl, GeneID, HGNC |
Source UniProt
Patents176
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 55885 | P22392 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 55886 | P22392 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 55887 | P22392 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 55888 | P22392 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 55889 | P22392 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5870 | P22392 | Espacenet |
| US 12415868 B1 | 2025-09-16 | 19 | P22392 | Espacenet |
| US 12415868 B1 | 2025-09-16 | 200 | P22392 | Espacenet |
| US 12415868 B1 | 2025-09-16 | 202 | P22392 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7149 | P22392 | Espacenet |
1 to 10 of 176
See all 176 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,206
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NME2 papers | Newest fiscal year |
|---|---|---|---|
| T32CA154274 | Training Grant in Cancer Biology | 9 | 2025 |
| ZIAES050165 | Structural Studies Of Post-Transcriptional Gene Regulation | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 7 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 5 | 2025 |
| T32CA009370 | Cancer Heterogeneity, Immunity, and Microenvironment (CHIME) Training Program | 4 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 3 | 2025 |
| P30CA134274 | UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT | 3 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 3 | 2025 |
| R01GM085319 | Function of Sequence-specific RNA Binding Proteins | 3 | 2025 |
1 to 10 of 1,206Source NIH's project files
See all 1,206 nih grantsPapers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual Randomness From Spatial and Temporal Variations in Stochastic Zinc Gallate Nanoclusters for PUF and TRNG Co-Driven Image Generation. | Adv Sci (Weinh) | 2026 | 42806503 | PubTator, text mining | PubMed |
| Author Correction: Effective in vivo RNA base editing via engineered cytidine deaminase APOBECs fused with PUF proteins. | Nat Commun | 2026 | 42586987 | PubTator, text mining | PubMed |
| NME3 promotes clear cell renal cell carcinoma progression and modulates TKI response through MFN1/2-dependent mitochondrial fusion and mitophagy suppression. | Oncogene | 2026 | 42432330 | PubTator, text mining | PubMed |
| Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metabolite. | Antimicrob Agents Chemother | 2026 | 42363837 | PubTator, text mining | PubMed |
| Heterologous expression of lipase gene in Cereibacter sphaeroides 2.4.1 driven by an anaerobic Photosynthesis-Inducible promoter. | J Genet Eng Biotechnol | 2026 | 42309595 | PubTator, text mining | PubMed |
| Stearoyl-CoA desaturase 5 (SCD5) in lipid remodeling: From molecular control to pathophysiology. | J Lipid Res | 2026 | 42285304 | PubTator, text mining | PubMed |
| Pharmacological evaluation of an ex vivo cervicovaginal HIV prevention model. | J Antimicrob Chemother | 2026 | 41873439 | PubTator, text mining | PubMed |
| Quantum Chemical Study of the Formation Mechanism of 5-Substituted N-Methylthiophen-2-amine and N-Methyl-1H-pyrrol-2-thiol from Allenylimidothioates. | J Org Chem | 2026 | 41871275 | PubTator, text mining | PubMed |
| The Potential Molecular Mechanisms and Key Genes of Early Deterioration of Parenchymal Lesions in Cerebral Venous Sinus Thrombosis. | Curr Neurovasc Res | 2026 | 41863408 | PubTator, text mining | PubMed |
| Systematic identification of variant-specific RNA structure-small molecule interactions exemplified by RNA G-quadruplexes. | Nat Commun | 2026 | 41857008 | PubTator, text mining | PubMed |
1 to 10 of 1,736
See all 1,736 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4831
GET https://conductscience.org/api/genes/v1/4831/patents?page=2